65,437 trials
Skin/Soft Tissue Infections · Methicillin Resistant Staphylococcus Aureus (MRSA)
Primary: Clinical Outcome in Participants With Baseline Methicillin-Resistant Staphylococcus Aureus (MRSA) at End of Study (EOS) for Per-Protocol (PP) Population — 84.1; 79.9…
Gastroesophageal Reflux
Primary: Number of Participants With Treatment Failure at 5 Years — 33; 19 participants
Prostate Cancer
Primary: Change in Serum Prostate Specific Antigen (PSA) of Prostate Cancer — 0.86 ng/mL — p==0.027
Digital Ulcers
Primary: Time to Complete Healing of Each Baseline DU
Postoperative Pain in Infants
Primary: Clearance of S-ketorolac and R+ Ketorolac in 2-6 Month Old Infants Following Surgery — 30.7; 6.5 ml/min
Vaccines, Pneumococcal Conjugate Vaccine
Primary: Percentage of Participants Achieving Antibody Level ≥ 0.35 μg/mL in the 13vPnC Group After the 3-Dose Infant Series — 100.0; 98.3; 100.0; 100.0 percentage of participants
Vaccines, Pneumococcal
Primary: Percentage of Participants Achieving Antibody Level ≥0.35 μg/mL in 13vPnC Group Relative to 7vPnC Group After the 3-Dose Infant Series — 98.2; 98.2; 77.5; 87.1…
Atrial Fibrillation · Tachycardia, Supraventricular · Arrhythmia
Primary: Rate of Symptomatic Atrial Tachycardia/Atrial Fibrillation Episodes Per Subject Per Month — 2.0; 1.8 Episodes per subject per month — p=0.629
Multiple Myeloma and Plasma Cell Neoplasm
Primary: Progression-free Survival (PFS) Rate at 12 Months — 79 percentage of participants
Carotid Artery Stenosis
Primary: Composite Major Adverse Event (MAE) Rate of Death, Myocardial Infarction, and Stroke at 30 Days Postprocedure — 10; 2; 1; 0 Participants — p=0.0001
Rheumatoid Arthritis
Primary: Total Number of Patients With Adverse Events — 27.8 Percentage of Patients
Cancer of the Esophagus
Primary: Panitumumab Maximum Tolerated Dose in Milligrams (mg) — 3.6 mg
Type 2 Diabetes Mellitus
Primary: Change From Baseline in Hemoglobin A1C (%) at Week 24 — -0.84; -0.16 Percentage of glycosylated hemoglobin — p=<0.001
Dwarfism, Pituitary
Primary: Change From Baseline in Serum Insulin Like Growth Factor-1 Standard Deviation Score (IGF-1 SDS) Levels at Week 4 — -2.04; -2.22; 1.38; 0.85 nanogram/millilter (ng/mL)…
Leukemia · Lymphoma
Primary: Number of Participants With Absolute Neutrophil Count Engraftment — 21 participant